XML 50 R5.htm IDEA: XBRL DOCUMENT v3.2.0.727
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
May. 30, 2015
May. 31, 2014
Feb. 28, 2015
Mar. 01, 2014
Operating activities:        
Net income $ 13,734 $ 10,655    
Adjustments to reconcile net income to net cash (used in) provided by operating activities:        
Impairment charges and store closing costs 168 2,314    
Depreciation and amortization 10,095 9,644    
Deferred income taxes (1,207) (1,131)    
Loss on disposals of property and equipment 19 252    
Gain on settlement of contingent consideration (329) 0    
Share-based compensation 2,390 2,127    
Excess tax benefits from share-based compensation (133) (1,046)    
Changes in operating assets and liabilities:        
Accounts receivable, net 441 (769)    
Merchandise inventories, net 20,717 10,574    
Other assets (5,601) 8,395    
Accounts payable (46,250) (11,954)    
Employee compensation (5,653) (11,026)    
Income taxes payable 9,072 (1,129)    
Other liabilities and accrued expenses (2,979) (2,687)    
Deferred credits from landlords 821 1,016    
Net cash (used in) provided by operating activities (4,695) 15,235    
Investing activities:        
Capital expenditures for property and equipment (18,879) (20,614)    
Acquisitions, net of cash acquired (8,278) (4,674)    
Proceeds from disposals of property and equipment 16 7    
Net cash used in investing activities (27,141) (25,281)    
Financing activities:        
Dividends paid to shareholders (4,193) (3,895)    
(Payments) proceeds from issuance of common stock, net of settlement of tax withholding obligations (176) 3,962    
Excess tax benefits from share-based compensation 133 1,046    
Purchases of treasury stock (31,304) (18,653)    
Purchase of redeemable noncontrolling interest 0 (9,000)    
Proceeds from repayment of related-party promissory note 0 4,090    
Net cash used in financing activities (35,540) (22,450)    
Net decrease in cash and cash equivalents (67,376) (32,496)    
Cash and cash equivalents at beginning of period 149,569 229,079 $ 229,079  
Cash and cash equivalents at end of period 82,193 196,583 149,569 $ 229,079
Supplemental disclosure of noncash operating and investing activities:        
Capital expenditures incurred but not yet paid $ 5,684 $ 5,520 $ 13,532 $ 9,200